Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytogenetics and genomics in CML and other myeloproliferative neoplasms.

Best practice & research. Clinical haematology - 1 Jun 2024

Kreipe Hans H, Schlegelberger Brigitte

Abstract excerpt

Chronic myeloid leukemia is defined by the presence of the Philadelphia translocation t (9; 22) resulting in the BCR::ABL1 fusion. The other myeloproliferative neoplasms (MPN) subtypes also carry typical chromosomal abnormalities, which however are not pathognomonic for a specific entity of MPN. According to the WHO classification the distinction between these entities is still based on the integration of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calreticulin
Share to Chromosome Aberrations
Share to Fusion Proteins, bcr-abl

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Myeloproliferative Disorders

Share to Receptors, Thrombopoietin

Share to Translocation, Genetic

Source

Identifiers

PMID: 39098796
DOI: 10.1016/j.beha.2024.101552

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytogenetics and genomics in CML and other myeloproliferative neoplasms.PMID 39098796Read ↗

Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia.Semantic proximity Read ↗

Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolutionSemantic proximity Read ↗

Genomics of Myeloproliferative Neoplasms.Semantic proximity Read ↗

Genomics of MPN progression.Semantic proximity Read ↗

Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape.Semantic proximity Read ↗

The role of cytogenetics and molecular biology in the diagnosis, treatment and monitoring of patients with chronic myeloid leukemiaSemantic proximity Read ↗

Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms.Semantic proximity Read ↗

The Role of New Technologies in Myeloproliferative NeoplasmsSemantic proximity Read ↗

Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approachesSemantic proximity Read ↗

Advances in molecular evaluation of myeloproliferative neoplasms.Semantic proximity Read ↗

Chronic myeloid leukemia: a type of MPNSemantic proximity Read ↗

Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.